Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halobetasol Propionate Lotion 0.05% in Plaque Psoriasis
NCT01610596Phase 2Completed
- Start
- Nov 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis. Started Nov 2011; status: completed.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01610596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610596.